Saturday 17 October 2026 Export PMN’s income statement to Excel — free account

Promis Neurosciences

PMN Healthcare Biotechnology

In the quarter to June 2026, EPS grew 82.3% and free cash flow fell 169.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

8.15 0.55 −6.32%

Follow PMN

Alert me

Market cap: $78.0M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: 3/9
Altman Z: −78.86
Beneish M: −7.40
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(355.80%)	(521.60%)	(115.73%)	(172.30%)
ROA Full definition →		(127.40%)	(282.76%)	(100.21%)	(127.57%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(316.67%)	3,230.77%	(68.84%)	(85.35%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(14.10)	(16.00)	(5.45)	(4.61)
Free Cash Flow Full definition →		(27.55)	(28.12)	(35.58)	(42.11)
Other line items
Cash ROIC Full definition →		(111.91%)	(574.82%)	(28.56%)	(40.93%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.94	0.71	0.88	1.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(14.10)	(16.00)	(5.45)	(4.61)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates